Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The Science of the Total Environment|December 24, 2023
Toxic effects of the heavy metal Cd on Apis cerana cerana (Hymenoptera: Apidae): Oxidative stress, immune disorders and disturbance of gut microbiotaZhongyu Li, Dezheng Guo, Chen Wang, et al.
Frontiers in Immunology|June 23, 2025
Povetacicept (ALPN-303; TACI vTD-Fc), an enhanced, potent dual inhibitor of BAFF and APRIL, ameliorates experimental autoimmune myasthenia gravis in C57BL/6N miceElena Rinaldi, Elisa Puleo, Alessandra Consonni, et al.
The Science of the Total Environment|April 26, 2024
Effects of abamectin nanocapsules on bees through host physiology, immune function, and gut microbiomeDezheng Guo, Ying Wang, Zhongyu Li, et al.
Clinical and Translational Science|November 4, 2024
A first-in-human, randomized study of the safety, pharmacokinetics and pharmacodynamics of povetacicept, an enhanced dual BAFF/APRIL antagonist, in healthy adultsRupert Davies, Stanford L Peng, Jason Lickliter, et al.
Environmental Pollution (Barking, Essex : 1987)|October 5, 2021
PM2.5 composition and sources in the San Joaquin Valley of California: A long-term study using ToF-ACSM with the capture vaporizerPeng Sun, Ryan N Farley, Lijuan Li, et al.
Arthritis Research & Therapy|January 6, 2022
Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse modelsCindy Orvain, Anne Cauvet, Alexis Prudent, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 27, 2023
Povetacicept, an Enhanced Dual APRIL/BAFF Antagonist That Modulates B Lymphocytes and Pathogenic Autoantibodies for the Treatment of Lupus and Other B Cell-Related Autoimmune DiseasesLawrence S Evans, Katherine E Lewis, Daniel DeMonte, et al.
Pageof 4